Biopharmaceutical Analysis & Statistics, January 2013 (p10)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

All regions

You might be interested in: Protein, Biomedical, Antibody, more »

271-310 of about 900 reports

Purchase Reports From Reputable Market Research Publishers

Insulin Like Growth Factor 1 (IGF-1) Activators -Pipeline Insights, 2014

Insulin Like Growth Factor 1 (IGF-1) Activators -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Insulin Like Growth Factor 1 (IGF-1) Activators-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Biopharmaceutical
Interferon-Alpha/Beta Receptor Binders -Pipeline Insights, 2014

Interferon-Alpha/Beta Receptor Binders -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Interferon-Alpha/Beta Receptor Binders-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Biopharmaceutical
Microsomal Triglyceride Transfer Protein (MTP) Inhibitors -Pipeline Insights, 2014

Microsomal Triglyceride Transfer Protein (MTP) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Microsomal Triglyceride Transfer Protein (MTP) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Biopharmaceutical
N-Cadherin Protein Antagonists -Pipeline Insights, 2014

N-Cadherin Protein Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“N-Cadherin Protein Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Biopharmaceutical
Non-Structural Protein 3 (NS3) Inhibitors -Pipeline Insights, 2014

Non-Structural Protein 3 (NS3) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Non-Structural Protein 3 (NS3) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Biopharmaceutical
Non-Structural Protein 4A Inhibitors -Pipeline Insights, 2014

Non-Structural Protein 4A Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Non-Structural Protein 4A Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Biopharmaceutical
Non-Structural Protein 5A Inhibitors -Pipeline Insights, 2014

Non-Structural Protein 5A Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Non-Structural Protein 5A Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Biopharmaceutical
Non-Structural Protein 5B Inhibitors -Pipeline Insights, 2014

Non-Structural Protein 5B Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Non-Structural Protein 5B Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Biopharmaceutical
p70S6 Kinase (p70S6K or 70-kDa Ribosomal Protein S6 Kinase) Inhibitors -Pipeline Insights, 2014

p70S6 Kinase (p70S6K or 70-kDa Ribosomal Protein S6 Kinase) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“p70S6 Kinase (p70S6K or 70-kDa Ribosomal Protein S6 Kinase) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism ...

  • Industries : Biopharmaceutical, Sport Nutritional
Protein Kinase C (PKC) Inhibitors -Pipeline Insights, 2014

Protein Kinase C (PKC) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Protein Kinase C (PKC) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Biopharmaceutical
Protein-Tyrosine Phosphatase (PTP) Inhibitors -Pipeline Insights, 2014

Protein-Tyrosine Phosphatase (PTP) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Protein-Tyrosine Phosphatase (PTP) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Biopharmaceutical
Rho Kinase (Rho-Associated Coiled-Coil Forming Protein Kinase or ROCK) Inhibitors -Pipeline Insights, 2014

Rho Kinase (Rho-Associated Coiled-Coil Forming Protein Kinase or ROCK) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Rho Kinase (Rho-Associated Coiled-Coil Forming Protein Kinase or ROCK) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across ...

  • Industries : Biopharmaceutical, Sport Nutritional
Serine Protease (Serine Endopeptidase) Inhibitors -Pipeline Insights, 2014

Serine Protease (Serine Endopeptidase) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Serine Protease (Serine Endopeptidase) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Biopharmaceutical
Silent Information Regulator 2 Protein (Sir2 Protein or Sirtuin) Inhibitors -Pipeline Insights, 2014

Silent Information Regulator 2 Protein (Sir2 Protein or Sirtuin) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Silent Information Regulator 2 Protein (Sir2 Protein or Sirtuin) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this ...

  • Industries : Biopharmaceutical
Synaptic Vesicle Protein 2A (SV2A) Binders -Pipeline Insights, 2014

Synaptic Vesicle Protein 2A (SV2A) Binders -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Synaptic Vesicle Protein 2A (SV2A) Binders-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Biopharmaceutical
Synaptosomal Associated Protein 25 (SNAP-25) Inhibitors -Pipeline Insights, 2014

Synaptosomal Associated Protein 25 (SNAP-25) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Synaptosomal Associated Protein 25 (SNAP-25) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Biopharmaceutical
Tumor Necrosis Factor (TNF) Agonists -Pipeline Insights, 2014

Tumor Necrosis Factor (TNF) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Tumor Necrosis Factor (TNF) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Biopharmaceutical
Tumor Necrosis Factor (TNF) Inhibitors -Pipeline Insights, 2014

Tumor Necrosis Factor (TNF) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Tumor Necrosis Factor (TNF) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Biopharmaceutical
Tumor Necrosis Factor Receptor (TNFR) Antagonists -Pipeline Insights, 2014

Tumor Necrosis Factor Receptor (TNFR) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Tumor Necrosis Factor Receptor (TNFR) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Biopharmaceutical
Vascular Adhesion Protein 1 (VAP-1) Inhibitors -Pipeline Insights, 2014

Vascular Adhesion Protein 1 (VAP-1) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Vascular Adhesion Protein 1 (VAP-1) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Biopharmaceutical
Glucagon-Like Peptide 2 (GLP-2) Agonists -Pipeline Insights, 2014

Glucagon-Like Peptide 2 (GLP-2) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Glucagon-Like Peptide 2 (GLP-2) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Biopharmaceutical
Heat Shock Protein 27 (Hsp27) Inhibitors -Pipeline Insights, 2014

Heat Shock Protein 27 (Hsp27) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Heat Shock Protein 27 (Hsp27) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Biopharmaceutical
Heat Shock Protein 70 (Hsp70) Inhibitors -Pipeline Insights, 2014

Heat Shock Protein 70 (Hsp70) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Heat Shock Protein 70 (Hsp70) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Biopharmaceutical
Insulin Like Growth Factor 2 (IGF-2) Inhibitors -Pipeline Insights, 2014

Insulin Like Growth Factor 2 (IGF-2) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Insulin Like Growth Factor 2 (IGF-2) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Biopharmaceutical
Protein Kinase C Beta (PKC-Beta) Inhibitors -Pipeline Insights, 2014

Protein Kinase C Beta (PKC-Beta) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Protein Kinase C Beta (PKC-Beta) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Biopharmaceutical
Protein-Tyrosine Phosphatase 1B (PTP1B) Inhibitors -Pipeline Insights, 2014

Protein-Tyrosine Phosphatase 1B (PTP1B) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Protein-Tyrosine Phosphatase 1B (PTP1B) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Biopharmaceutical
Tumor Necrosis Factor Alpha (TNF-a) Agonists -Pipeline Insights, 2014

Tumor Necrosis Factor Alpha (TNF-a) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Tumor Necrosis Factor Alpha (TNF-a) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Biopharmaceutical
Sports Nutrition in Hong Kong, China

Sports Nutrition in Hong Kong, China

  • $ 898
  • Industry report
  • July 2014
  • by Euromonitor International

Sports nutrition benefited from the health and wellness trend during the review period, with a growing number of consumers seeking to increase their participation in sports, lose weight and become healthier. ...

  • Industries : Sport Nutritional, Biopharmaceutical
  • Countries : China
Research on China Monoclonal Antibody (McAB) Industry, 2014

Research on China Monoclonal Antibody (McAB) Industry, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Huidian Research

Please note: The report is Chinese version. It will provide the English version in two business days. Research on China Monoclonal Antibody (McAB) Industry, 2014 mainly carries on in-depth analysis on ...

  • Industries : Biopharmaceutical
  • Countries : China
Vaccine Partnering Terms and Agreements

Vaccine Partnering Terms and Agreements

  • $ 2 995
  • Industry report
  • July 2014
  • by Currentpartnering

The Vaccine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare ...

  • Industries : Biopharmaceutical
  • Countries : United States

31 Companies

Read our Company Profiles

Johnson and Johnson

United States

Biogen Idec

United States

GlaxoSmithKline P.L.C.

United States

Abbott Laboratories

United States

Merck KGaA

Germany

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.